[Federal Register Volume 88, Number 99 (Tuesday, May 23, 2023)]
[Notices]
[Pages 33147-33148]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10957]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-0920]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Data Collection Through Web Based Surveys 
for Evaluating Act Against AIDS Social Marketing Campaign Phases 
Targeting Consumers'' to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
February 17, 2023 to obtain comments from the public and affected 
agencies. CDC received two comments related to the previous notice. 
This notice serves to allow an additional 30 days for public and 
affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Data Collection Through Web Based Surveys for Evaluating Act 
Against AIDS Social Marketing Campaign Phases Targeting Consumers (OMB 
Control No. 0920-0920, Exp. 05/31/2023)--Extension--National Center for 
HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    In response to the continued HIV epidemic in our country, in 2009 
CDC launched the Let's Stop HIV Together campaign (formerly known as 
Act Against AIDS), a multifaceted communication campaign to reduce HIV 
incidence in the United States. CDC has released the campaign in 
phases, with some of the phases running concurrently. Each phase of the 
campaign uses mass media and direct-to-consumer channels to deliver 
messages. Some campaigns provide basic education and increase awareness 
of HIV/AIDS among the general public while others emphasize HIV 
prevention and testing among specific subgroups or communities at 
greatest risk of infection. CDC also develops new messages to address 
changes in prevention science and subpopulations affected by HIV.
    CDC has used a generic clearance (OMB No. 0920-0920) to facilitate 
OMB approval of information collection needed to assess the 
effectiveness of social marketing messages aimed at increasing HIV/AIDS 
awareness, increasing prevention behaviors, and improving HIV testing 
rates among consumers. Specifically, in 2022 CDC received OMB approval 
to collect information for evaluating the acceptability and potential 
effectiveness of proposed concepts, messages, and taglines for a 
component of the Let's Stop HIV Together campaign (``Development of 
Messages for the Let's Stop HIV Together National Campaign''). This 
component emphasizes proven, effective prevention strategies, such as 
pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP). 
Information collection has been initiated but has not been completed.
    CDC is requesting OMB approval to extend the generic clearance and 
to complete information collection that supports campaign development 
and evaluation. Respondents will be recruited through national opt-in 
email lists, the internet, and external partnerships with community-
based and membership organizations that work with or represent 
individuals from targeted populations (e.g., National Urban League, the 
National Medical Association).
    To identify and reach target audiences, screening questions for up 
to 30,880 potential respondents may address one or more of the 
following items: Race/ethnicity, sexual behavior, sexual orientation, 
gender identity, HIV testing history, HIV status, and injection drug 
use. In addition, up to 5,445 respondents will be asked to complete a 
self-administered survey at home on a personal computer. Each targeted 
campaign survey will have a core set of items asked in all rounds, as 
well as a module of questions relating to specific Let's Stop HIV 
Together phases and activities.
    OMB approval is requested for three years and there is no cost to 
the respondents other than their time. The total estimated annualized 
burden is 3,751 hours.

[[Page 33148]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female) aged 18   Study Screener..........          30,880               1            2/60
 years and older.
                                        Survey Module...........           5,445               1           30/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-10957 Filed 5-22-23; 8:45 am]
BILLING CODE 4163-18-P